Kaya, E. Et Al. 2025. Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.. Hepatology forum , vol.6, no.3 , 111-115.

Kaya, E., Aksoy, S., Oruc, N., Tasdemir, C., Cengiz, B. I., Keklikkiran, C., ... Yilmaz, Y.(2025). Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.. Hepatology forum , vol.6, no.3, 111-115.

Kaya, Eda Et Al. "Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.," Hepatology forum , vol.6, no.3, 111-115, 2025

Kaya, Eda Et Al. "Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.." Hepatology forum , vol.6, no.3, pp.111-115, 2025

Kaya, E. Et Al. (2025) . "Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.." Hepatology forum , vol.6, no.3, pp.111-115.

@article{article, author={Eda Kaya Et Al. }, title={Non-invasive tests for resmetirom treatment fail to accurately define the target population: Evidence from a biopsy-proven MASLD cohort.}, journal={Hepatology forum}, year=2025, pages={111-115} }